With a one year PEG ratio of 0.25, Elanco Animal Health Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than merely 4.93% of US stocks.
ELAN's went public 1.81 years ago, making it older than only 3.59% of listed US stocks we're tracking.
Price to trailing twelve month operating cash flow for ELAN is currently 39.44, higher than 90.97% of US stocks with positive operating cash flow.
Stocks with similar financial metrics, market capitalization, and price volatility to Elanco Animal Health Inc are NTCT, MMSI, QBAK, ENV, and HPE.
Elanco Animal Health Incorporated (ELAN) Company Bio
Elanco Animal Health Incorporated operates as an animal health care company. The Company develops, manufactures, and markets products for companion and food animals. Elanco Animal Health serves clients worldwide. The company is based in Greenfield, Indiana.
ELAN Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Elanco Animal Health Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Elanco Animal Health Inc ranked in the 0th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 100%. As for the metrics that stood out in our discounted cash flow analysis of Elanco Animal Health Inc, consider:
Its compound free cash flow growth rate, as measured over the past 1.67 years, is -0.78% -- higher than only 0.38% of stocks in our DCF forecasting set.
As a business, Elanco Animal Health Inc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than merely 0% of stocks generating free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as ELAN, try ABMC, AGHC, ALC, ANGO, and CSII.
NEW YORK, NY / ACCESSWIRE / July 12, 2020 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Elanco Animal Health Incorporated (NYSE:ELAN) between January 10, ...
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of March 31st, a week after the market trough. Now, we are […]
New York, New York--(Newsfile Corp. - July 10, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE:ELAN) of the July 20, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Elanco stock or options between January 10, 2020 and May 6, 2020 ...